Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hobeika

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Journal of Translational Medicine|February 14, 2012
Phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibition [corrected]Erika Hamilton, Kimberly Blackwell, Amy C Hobeika, et al.
Cancer Investigation|August 7, 2003
Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNAMichael A Morse, Smita K Nair, Paul J Mosca, et al.
Breast Cancer Research : BCR|June 9, 2012
Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cellsXiu-Rong Ren, Junping Wei, Gangjun Lei, et al.
International Journal of Cancer|October 27, 2009
Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivoMichael A Morse, Junping Wei, Zachary Hartman, et al.
Human Vaccines & Immunotherapeutics|February 8, 2024
Vaccines targeting <i>ESR1</i> activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancerGabrielle P Dailey, Christopher A Rabiola, Gangjun Lei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2019
Vaccine-Induced Memory CD8<sup>+</sup> T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational StudyErika J Crosby, William Gwin, Kimberly Blackwell, et al.
Cancer Immunology, Immunotherapy : CII|April 30, 2013
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patientsMichael A Morse, Arvind Chaudhry, Elizabeth S Gabitzsch, et al.
Annals of Surgery|May 10, 2013
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancerMichael A Morse, Donna Niedzwiecki, John L Marshall, et al.
The British Journal of Surgery|January 10, 2020
Impact of cirrhosis in patients undergoing laparoscopic liver resection in a nationwide multicentre surveyC Hobeika, D Fuks, F Cauchy, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal of Translational Medicine|February 14, 2012
Phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibition [corrected]Erika Hamilton, Kimberly Blackwell, Amy C Hobeika, et al.
Cancer Investigation|August 7, 2003
Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNAMichael A Morse, Smita K Nair, Paul J Mosca, et al.
Breast Cancer Research : BCR|June 9, 2012
Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cellsXiu-Rong Ren, Junping Wei, Gangjun Lei, et al.
International Journal of Cancer|October 27, 2009
Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivoMichael A Morse, Junping Wei, Zachary Hartman, et al.
Human Vaccines & Immunotherapeutics|February 8, 2024
Vaccines targeting <i>ESR1</i> activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancerGabrielle P Dailey, Christopher A Rabiola, Gangjun Lei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2019
Vaccine-Induced Memory CD8<sup>+</sup> T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational StudyErika J Crosby, William Gwin, Kimberly Blackwell, et al.
Cancer Immunology, Immunotherapy : CII|April 30, 2013
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patientsMichael A Morse, Arvind Chaudhry, Elizabeth S Gabitzsch, et al.
Annals of Surgery|May 10, 2013
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancerMichael A Morse, Donna Niedzwiecki, John L Marshall, et al.
The British Journal of Surgery|January 10, 2020
Impact of cirrhosis in patients undergoing laparoscopic liver resection in a nationwide multicentre surveyC Hobeika, D Fuks, F Cauchy, et al.
Pageof 6